Vipul Share Price
9.93-0.38 (-3.69%)
+17.79% past 1 Year
Financial overview
Peer Comparison
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Cash Flow
Consolidated
Standalone
₹
%
Fundamental Ratios
Consolidated
Standalone
Vipul Share Price
9.93-0.38 (-3.69%)
+17.79% past 1 Year
Technical meters

No results found
Pivot
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Vipul Share Price
9.93-0.38 (-3.69%)
+17.79% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly

No results found
Bulk & block deals

No results found
Insider trading & SAST

No results found
Vipul Share Price
9.93-0.38 (-3.69%)
+17.79% past 1 Year
Corporate Actions
Date
Type
Details
Company details
Vipul Share Price
9.93-0.38 (-3.69%)
+17.79% past 1 Year
Corporate filings & documents

No corporate filings & documents found
Vipul Share Price
9.93-0.38 (-3.69%)
+17.79% past 1 Year
News
MapmyIndia Partners With Mumbai Metro For Real Time Metro Data
Equity
MAPMYINDIA
Go Digit Reports Rs 70.05 Crores BSE Block Trade Involving 2,500,016 Shares
Equity
GODIGIT
Go Digit Reports Rs 55.75 Crores NSE Block Trade At Rs 280.35
Equity
GODIGIT
Can Fin Homes Requires Rs 8,000 Crores Second Half Disbursements
Equity
CANFINHOME
Tata Power Builds 2.8 GW Data Centre Pipeline Across 18 Major Players
Equity
TATAPOWER
Max Healthcare Reports Rs 31.70 Crore BSE Block Trade
Equity
MAXHEALTH
Max Healthcare Reports Rs 55.08 Crore BSE Block Trade At Rs 858
Equity
MAXHEALTH
REC Limited Reports NSE Block Trade Worth Rs 31.11 Crores
Equity
RECLTD
Income Tax Department Searches Park Medi World Corporate Premises
Equity
PARKHOSPS
Poonawalla Fincorp Reports Rs 66.05 Crores NSE Block Trade
Equity
POONAWALLA
JSW Steel Reports Rs 65.62 Crores NSE Block Trade
Equity
JSWSTEEL
JSW Steel Reports Rs 555.17 Crores BSE Block Trade
Equity
JSWSTEEL
Meesho Reports Rs 1167.43 Crores NSE Block Trade At Rs 231.18
Equity
MEESHO
India Ten Year Government Bond Yield Rises To 7.4112 Percent
Currency
Indian Rupee Opens Stronger Against US Dollar At 95.01
Currency
Tata Elxsi Sees Stronger H2 Led By Healthcare And Life Sciences
Equity
TATAELXSI
Bernstein Maintains Buy On Zydus Lifesciences After Fyb206 Review Acceptance
Equity
ZYDUSLIFE
JPMorgan Maintains Neutral Rating On Tata Elxsi With Rs 3,200 Target
Equity
TATAELXSI
JPMorgan Maintains Overweight Rating On ICICI Prudential Life
Equity
ICICIPRULI
Nomura Maintains Buy On ICICI Prudential Life Despite VNB Margin Miss
Equity

